Company Overview and News


Add PFIZER
to your dashboard

Headline News

Meet Your New Boss: An Algorithm - WSJ

9h wsj
Uber Technologies Inc. and other pioneers of the so-called gig economy became some of the world’s most valuable private companies by using apps and algorithms to hand out tasks to an army of self-employed workers. (51-0)

Koch-Backed Business Group Splinters in Climate-Change Dispute - Bloomberg

2017-12-09 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (35-0)

Why Trickle Down Doesn't Work

2017-12-08 seekingalpha
Tax cuts for the wealthy doesn't trickle down, at least not in the US, the evidence is clear. (18-0)

Healthy Earnings Visibility Keep Pfizer (PFE) a Buy

2017-12-08 investorplace
The current recommendation of Buy for Pfizer Inc (NYSE:PFE) has been derived by using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for the last month. (16-0)

Pfizer breast cancer drug superior to chemotherapy in Phase III study

2017-12-08 reuters
(Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc (PFE.N) drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday. (16-0)

Pfizer breast cancer drug superior to chemotherapy in Phase III study

2017-12-08 channelnewsasia
Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday. (16-0)

Pfizer breast cancer drug superior to chemotherapy in late stage study - Channel NewsAsia

2017-12-08 channelnewsasia
Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday. (16-0)

3 Must-Own Vanguard Funds to Buy Now

2017-12-07 investorplace
There are many beginning investors out there. That’s okay, because we all have to begin somewhere. Some investors just want to find a reasonable place to invest their money and forget about it. Others are looking for a place to park funds for a while as they work out their risk-adjusted diversified long-term strategy. (127-0)

Pfizer Reports Updated Data from Phase III Study on Ibrance

2017-12-07 zacks
Pfizer Inc. (PFE - Free Report) announced encouraging new data of a post-hoc analysis from a phase III study, evaluating the combination of its breast cancer drug, Ibrance (palbociclib), with Novartis' (NVS - Free Report) Femara (letrozole) for the first-line treatment of ER+, HER2- metastatic breast cancer. (60-0)

BRIEF-Pfizer Inc Announces Private Exchange Offer For Its 6.500 Per Cent Notes Due 2038

2017-12-07 reuters
* PFIZER INC. ANNOUNCES (I) PRIVATE EXCHANGE OFFER FOR ITS 6.500 PER CENT. NOTES DUE 2038 OPEN TO CERTAIN INVESTORS AND RELATED TENDER OFFER OPEN TO ALL INVESTORS AND (II) TENDER OFFER FOR ITS 5.750 PER CENT. NOTES DUE 2021 AND RELATED SOLICITATION OF CONSE (16-0)

Pfizer Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2017-12-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (16-0)

A Potential First Since the Civil War: Tax Cuts for Whiskey Makers

2017-12-07 wsj
BROWSER UPDATE To gain access to the full experience, please upgrade your browser: Chrome | Safari | Firefox | Internet Explorer (210-1)

Gene-therapy approach to hemophilia finds success in study, Spark stock surges - MarketWatch

2017-12-06 marketwatch
Spark Therapeutics Inc. ONCE, -1.78% stock surged Wednesday afternoon after the company announced positive results from a study of a gene-therapy approach to hemophilia. The drug, developed and tested in a collaboration with Pfizer Inc. PFE, -0.04% involves a single injection meant to help those suffering from hemophilia B, a disease that keep blood from clotting and is typically treated with regular and costly infusions. (18-0)

Viagra goes generic: Pfizer to launch own little white pill

2017-12-06 nzherald.co.nz
TRENTON, N.J. (AP) — The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first generic competition next week. (16-0)

Bear's Last CEO Finds New Challenge Holding Guggenheim Together - Bloomberg

2017-12-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (108-0)